Malignancy after Kidney Transplantation with Alemtuzumab Induction.

被引：0
|
作者：
Wu, C. M. [1 ]
Bei, L. [1 ]
Unruh, M. [1 ]
Shapiro, R. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
51
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of Alemtuzumab Compared to Rabbit Anti-Thymocyte Globulin as Induction for Secondary Transplant after a Primary Transplant with Alemtuzumab Induction.
    Fose, J. L.
    Jorgenson, M. R.
    Leverson, G. E.
    Redfield, R. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 816 - 816
  • [32] MALIGNANCY COMPLICATIONS AFTER KIDNEY TRANSPLANTATION, SHOULD WE USE INDUCTION THERAPY?
    Molina, Maria
    Gonzalez, Esther
    Cabrera, Jimena
    Hernandez, Ana
    Polanco, Natalia
    Gutierrez, Eduardo
    Morales, Enrique
    Praga, Manuel
    Andres, Amado
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 1602 - 1602
  • [33] Haematological Autoimmune Disorders Following Alemtuzumab Induction in Kidney Transplantation
    Charif, R.
    Chan, K.
    Galliford, J.
    Mclean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 290 - 290
  • [34] Alemtuzumab Induction and Antibody-Mediated Rejection in Kidney Transplantation
    Noureldeen, T.
    Albekioni, Z.
    Machado, L.
    Muddana, N.
    Marcus, R. J.
    Hussain, S. M.
    Sureshkumar, K. K.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (10) : 3405 - 3407
  • [35] ALEMTUZUMAB OR BASILIXIMAB AS ANTIBODY INDUCTION FOR SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION
    Kansal, Nisheeth
    Wilson, Colin
    French, Jeremy
    Jacques, Bryan
    Manas, Derek
    White, Steve
    TRANSPLANT INTERNATIONAL, 2013, 26 : 43 - 43
  • [36] Delayed allograft inflammation following alemtuzumab induction for kidney transplantation
    Heilman, Raymond L.
    Khamash, Hasan A.
    Smith, Maxwell L.
    Chakkera, Harini A.
    Moss, Adyr A.
    Reddy, Kunam S.
    CLINICAL TRANSPLANTATION, 2013, 27 (05) : 772 - 780
  • [37] Alemtuzumab Induction and Post-Transplant Glomerulonephritis in Kidney Transplantation
    Koutroutsos, K.
    Willicombe, M.
    Charif, R.
    Roufosse, C.
    Loucaidou, M.
    Cook, T.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 534 - 535
  • [38] Opportunistic Infections After Induction With Alemtuzumab or Basiliximab: A 3-Year Kidney Transplantation Experience
    Florescu, Diana F.
    Seaman, Jonathan A.
    Kalil, Andre C.
    Qiu, Fang
    Bremers, Douglas
    Westphal, Scott G.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (03) : 1058 - 1063
  • [39] Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death
    Schadde, Erik
    D'Alessandro, Anthony M.
    Knechtle, Stuart J.
    Odorico, Jon
    Becker, Yolanda
    Pirsch, John
    Sollinger, Hans
    Fernandez, Luis A.
    TRANSPLANT INTERNATIONAL, 2008, 21 (07) : 625 - 636
  • [40] Biopsies for Delayed Graft Function After Alemtuzumab Induction in Kidney Transplantation: The Incidence of Early Rejection After Alemtuzumab Is Very Low but Not Negligible.
    McGuire, E.
    Roufosse, C.
    Cook, T.
    Ashby, D.
    Cairns, T.
    Galliford, J.
    Willicombe, M.
    Taube, D.
    McLean, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 453 - 453
12345